Finance Watch: Bain Capital Raises $3bn For Fourth Life Sciences Fund
Candid, Superluminal, PanTera, F2G Raise Mega-Rounds
Private Company Edition: Bain will invest across private and public drug, device, diagnostic and tool companies. Also, Candid debuted with $370m in initial funding, Superluminal closed a $120m series A round, PanTera raised €93m ($102.4m) in series A cash and F2G brought in $100m.
